Bioscision Pharma Inc.
$0.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2025-2026
- Agreement period
- July 28, 2025 – September 30, 2026
- Reference
- nrc-cnrc:172-2025-2026-Q3-1033986
Published purpose
BioScision Pharma operates in a 65,000 SF drug manufacturing facility in Winnipeg Manitoba. BioScision will leverage its advanced drug manufacturing facility and experience to begin formulating, compounding, filling, finishing and testing, and distributing in-demand off-patent essential animal health drugs.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions